Optimizing Use of SGLT2 Inhibitors and Other Evidence-Based Therapies to Improve Outcomes in Patients with Type 2 Diabetes and Chronic Kidney Disease: An Opportunity for Pharmacists

Roles

Author

Document Type

Article

Publication Date

1-1-2022

Publication Title

American Journal of Health-System Pharmacy

DOI

10.1093/ajhp/zxab271

Share

COinS